ArticleJournal for immunotherapy of cancer2021

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.

Ryan Michael Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.